Jennifer K. Gajan, Ph.D.
Affiliations: | 2013 | Pharmaceutical Sciences and Pharmacogenomics | University of California, San Francisco, San Francisco, CA |
Area:
Pharmacy, Cell BiologyGoogle:
"Jennifer Gajan"Parents
Sign in to add mentor| Neil P. Shah | grad student | 2013 | UCSF | |
| (Mechanisms of Action of Kinase Inhibitors in Chronic Myeloid Leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gajan J, Lasater E, Tajon C, et al. (2013) Abstract 4308: A model of oncogene addiction: BCR-ABL hijacks signaling through a MEK-dependent process and inhibits growth factor-mediated signal transduction. Cancer Research. 73: 4308-4308 |
| Gajan J, Oses-prieto J, Lasater EA, et al. (2011) Abstract 2923: Phosphoproteomic assessment of CML cells following transient potent inhibition with dasatinib is associated with durable alteration of the STAT5 and RAF/MEK/ERK pathways Cancer Research. 71: 2923-2923 |
| Gajan J, Kasap C, Shah N. (2010) Abstract 1659: The mechanism of action of clinically effective dual Abl/Aurora kinase inhibitors does not involve BCR-ABL inhibition Cancer Research. 70: 1659-1659 |